The Role of the MAP-Kinase Superfamily in β-Amyloid Toxicity

The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postu...

Full description

Saved in:
Bibliographic Details
Published inMetabolic brain disease Vol. 16; no. 3-4; pp. 175 - 185
Main Authors Daniels, Willie M.U., Hendricks, Jacobus, Salie, Ruduwaan, Taljaard, Joshua J.F.
Format Journal Article
LanguageEnglish
Published New York, NY Springer 01.12.2001
Subjects
Online AccessGet full text
ISSN0885-7490
1573-7365
DOI10.1023/A:1012541011123

Cover

Abstract The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.
AbstractList The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.
The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.
The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta -amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta -amyloid. Neuroblastoma (N2 alpha ) cells were used in all experiments. The cells were exposed to 50, 100, and 500 mu M glutamate, and 10, 30, and 50 mu M beta -amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2 alpha cells with beta -amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta -amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta -amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.
Author Daniels, Willie M.U.
Hendricks, Jacobus
Taljaard, Joshua J.F.
Salie, Ruduwaan
Author_xml – sequence: 1
  givenname: Willie M.U.
  surname: Daniels
  fullname: Daniels, Willie M.U.
– sequence: 2
  givenname: Jacobus
  surname: Hendricks
  fullname: Hendricks, Jacobus
– sequence: 3
  givenname: Ruduwaan
  surname: Salie
  fullname: Salie, Ruduwaan
– sequence: 4
  givenname: Joshua J.F.
  surname: Taljaard
  fullname: Taljaard, Joshua J.F.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13435455$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11769330$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9LxDAQxYMouq6evUkveqtmkiZtBQ9l8R8qiq7nkE0nGGmbtemC-7X8IH4mu7gqCuJlZg6_92De2ySrjW-QkB2gB0AZPyyOgAITST8BGF8hAxApj1MuxSoZ0CwTcZrkdINshvBEKeUC8nWyAZDKnHM6IMfjR4zufIWRt1HX39fFbXzpGh0wup9NsbW6dtU8ck309hoX9bzyrozG_sUZ1823yJrVVcDt5R6Sh9OT8eg8vro5uxgVV7HhIuliTJmRLM2ESXSG-YRTKzUDmyQTgElugGcGjTXAEEtZJjqnNislSi0k1zTjQ7L_4Ttt_fMMQ6dqFwxWlW7Qz4JKGZe5BPgXhIwLxtMFuLsEZ5MaSzVtXa3bufpMpgf2loAORle21Y1x4ZvjSf-aED0nPjjT-hBatKoPRnfON12rXaWAqkVTqlA_mup1h790X9Z_KN4BZpKRjw
CODEN MBDIEE
CitedBy_id crossref_primary_10_1016_j_ejphar_2013_11_034
crossref_primary_10_1111_j_1471_4159_2004_02778_x
crossref_primary_10_1016_j_yexcr_2005_12_009
crossref_primary_10_1007_BF03033283
crossref_primary_10_1039_c3cp44539a
crossref_primary_10_1371_journal_pone_0011820
crossref_primary_10_4303_bda_D110136
crossref_primary_10_1515_revneuro_2018_0008
crossref_primary_10_3389_fncel_2019_00437
crossref_primary_10_3390_ijms21145035
crossref_primary_10_1016_j_neures_2010_10_004
crossref_primary_10_1016_j_neuroscience_2008_02_061
crossref_primary_10_1074_jbc_M610390200
crossref_primary_10_1016_j_neuropharm_2012_07_035
crossref_primary_10_1046_j_1471_4159_2003_01831_x
crossref_primary_10_1007_s11011_017_0118_x
crossref_primary_10_1016_S0197_4580_03_00126_X
crossref_primary_10_1016_j_physbeh_2015_05_029
crossref_primary_10_1111_jnc_12102
crossref_primary_10_1111_j_1745_7254_2005_00158_x
crossref_primary_10_1016_j_neuroscience_2010_05_069
crossref_primary_10_1016_j_pneurobio_2004_06_002
crossref_primary_10_1111_j_1365_2990_2004_00569_x
crossref_primary_10_1007_s10059_012_2247_8
crossref_primary_10_1196_annals_1332_005
crossref_primary_10_1097_01_jnen_0000235853_70092_ba
crossref_primary_10_1371_journal_pone_0286495
crossref_primary_10_3390_biomedicines9010027
crossref_primary_10_1007_s11064_005_6872_x
crossref_primary_10_1111_j_1471_4159_2010_06687_x
crossref_primary_10_1016_j_neuroscience_2008_08_022
crossref_primary_10_1007_s10616_016_9980_3
crossref_primary_10_1111_j_1440_1681_2012_12000_x
crossref_primary_10_4028_www_scientific_net_KEM_288_289_537
crossref_primary_10_1111_j_1471_4159_2007_04869_x
Cites_doi 10.1046/j.1471-4159.1999.0731181.x
10.1046/j.1471-4159.1995.65031282.x
10.1016/S0301-0082(99)00042-8
10.1046/j.1471-4159.1998.70052082.x
10.1073/pnas.90.17.7951
10.1074/jbc.273.13.7228
10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W
10.1046/j.1460-9568.2000.00164.x
10.1111/j.1600-079X.1998.tb00370.x
10.1016/S0955-0674(97)80061-0
10.1046/j.1471-4159.1999.0722248.x
10.1046/j.1471-4159.1997.69010273.x
10.1016/S0304-3940(00)01229-5
10.1046/j.1471-4159.1995.65041487.x
10.1021/bi990438f
10.1016/S0091-679X(08)61930-5
10.1096/fasebj.9.9.7601337
10.1016/0092-8674(94)90131-7
10.1074/jbc.274.33.23570
10.1016/S0169-328X(00)00025-5
10.1006/jmcc.1999.0959
10.1093/ajcn/71.2.621s
10.1016/S1050-1738(98)00012-7
10.1161/01.RES.83.4.345
10.1016/S0006-8993(97)00043-7
10.1016/S0006-8993(00)02965-6
10.1016/0003-2697(76)90527-3
ContentType Journal Article
Copyright 2002 INIST-CNRS
Copyright_xml – notice: 2002 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
C1K
7X8
DOI 10.1023/A:1012541011123
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Toxicology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7365
EndPage 185
ExternalDocumentID 11769330
13435455
10_1023_A_1012541011123
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-Y2
-~C
-~X
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1N0
1SB
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CITATION
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LLZTM
M1P
M2M
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
YLTOR
Z45
ZMTXR
ZOVNA
ZXP
~A9
~EX
~KM
IQODW
-4W
-56
-5G
-BR
-EM
3V.
ADINQ
CGR
CUY
CVF
ECM
EIF
GQ6
NPM
Z7U
Z83
Z87
Z8O
Z8W
Z91
7TK
7U7
C1K
PUEGO
7X8
ID FETCH-LOGICAL-c354t-e72c62785c4a8e9b30f6a21f44b11b9c138cecfc12eed6d4a90f8d6e6a563a083
ISSN 0885-7490
IngestDate Fri Sep 05 02:46:55 EDT 2025
Fri Sep 05 00:09:02 EDT 2025
Wed Feb 19 02:01:11 EST 2025
Mon Jul 21 09:14:45 EDT 2025
Tue Jul 29 02:13:39 EDT 2025
Thu Apr 24 23:12:03 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3-4
Keywords Human
Cell culture
Nervous system diseases
Extracellular signal-regulated protein kinase
Enzyme
Pathogenesis
Mitogen-activated protein kinase
Glutamate
Hydrogen Peroxides
Cerebral disorder
Neuron
β Amyloid protein
Central nervous system disease
Degenerative disease
Apoptosis
Brain (vertebrata)
Language English
License https://www.springernature.com/gp/researchers/text-and-data-mining
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c354t-e72c62785c4a8e9b30f6a21f44b11b9c138cecfc12eed6d4a90f8d6e6a563a083
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 11769330
PQID 18352371
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_72369611
proquest_miscellaneous_18352371
pubmed_primary_11769330
pascalfrancis_primary_13435455
crossref_citationtrail_10_1023_A_1012541011123
crossref_primary_10_1023_A_1012541011123
PublicationCentury 2000
PublicationDate 2001-12-01
PublicationDateYYYYMMDD 2001-12-01
PublicationDate_xml – month: 12
  year: 2001
  text: 2001-12-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Metabolic brain disease
PublicationTitleAlternate Metab Brain Dis
PublicationYear 2001
Publisher Springer
Publisher_xml – name: Springer
References P.W. Conrad (346417_CR6) 1999; 274
M.M. Bradford (346417_CR3) 1976; 71
P.H. Sugden (346417_CR29) 1998; 83
A. Klegeris (346417_CR12) 1997; 49
L. New (346417_CR19) 1998; 8
M.P. Mattson (346417_CR17) 1995; 46
M.J. Robinson (346417_CR23) 1997; 9
F. Mailly (346417_CR15) 1999; 73
R. Seger (346417_CR28) 1995; 9
A. Clerk (346417_CR5) 1998; 273
T. Harkany (346417_CR9) 2000; 12
M. Kurino (346417_CR13) 1995; 65
A. Parpura-Gill (346417_CR22) 1997; 754
T. Satoh (346417_CR26) 2000; 288
X. Huang (346417_CR10) 1999; 38
K. Mielke (346417_CR18) 2000; 61
A.J. Anderson (346417_CR1) 1995; 65
W.M.U. Daniels (346417_CR7) 1998; 24
N.J. Marshall (346417_CR16) 1995; 5
Y. Christen (346417_CR4) 2000; 71
T. Omura (346417_CR20) 1999; 31
S. Samanta (346417_CR25) 1998; 70
C. Behl (346417_CR2) 1994; 77
F.J. Ekinci (346417_CR8) 2000; 76
W.M. Zawada (346417_CR30) 2001; 891
D.T. Loo (346417_CR14) 1993; 90
M.A. Schwarzschild (346417_CR27) 1999; 72
M.A. Pappolla (346417_CR21) 1998; 152
J. Rogers (346417_CR24) 2000; 3
J.N. Keller (346417_CR11) 1997; 69
10438538 - J Biol Chem. 1999 Aug 13;274(33):23570-6
7627094 - Growth Regul. 1995 Jun;5(2):69-84
10759064 - Prog Neurobiol. 2000 May;61(1):45-60
9069255 - Curr Opin Cell Biol. 1997 Apr;9(2):180-6
7601337 - FASEB J. 1995 Jun;9(9):726-35
7541884 - Methods Cell Biol. 1995;46:187-216
14987568 - Trends Cardiovasc Med. 1998 Jul;8(5):220-8
942051 - Anal Biochem. 1976 May 7;72:248-54
8367446 - Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5
10386999 - Biochemistry. 1999 Jun 15;38(24):7609-16
10971616 - Eur J Neurosci. 2000 Aug;12(8):2735-45
10681270 - Am J Clin Nutr. 2000 Feb;71(2):621S-629S
10349832 - J Neurochem. 1999 Jun;72(6):2248-55
10371701 - J Mol Cell Cardiol. 1999 Jun;31(6):1269-79
9721691 - Circ Res. 1998 Aug 24;83(4):345-52
9510431 - J Pineal Res. 1998 Mar;24(2):78-82
10762716 - Brain Res Mol Brain Res. 2000 Mar 29;76(2):389-95
7643105 - J Neurochem. 1995 Sep;65(3):1282-9
10461910 - J Neurochem. 1999 Sep;73(3):1181-8
11164822 - Brain Res. 2001 Feb 9;891(1-2):185-96
7561842 - J Neurochem. 1995 Oct;65(4):1487-98
9272645 - J Neurosci Res. 1997 Jul 15;49(2):229-35
9572294 - J Neurochem. 1998 May;70(5):2082-90
9516415 - J Biol Chem. 1998 Mar 27;273(13):7228-34
9546346 - Am J Pathol. 1998 Apr;152(4):871-7
10876086 - Neurosci Lett. 2000 Jul 14;288(2):163-6
8004671 - Cell. 1994 Jun 17;77(6):817-27
9134960 - Brain Res. 1997 Apr 18;754(1-2):65-71
9202320 - J Neurochem. 1997 Jul;69(1):273-84
References_xml – volume: 73
  start-page: 1181
  year: 1999
  ident: 346417_CR15
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.0731181.x
– volume: 65
  start-page: 1282
  year: 1995
  ident: 346417_CR13
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1995.65031282.x
– volume: 61
  start-page: 45
  year: 2000
  ident: 346417_CR18
  publication-title: Prog. Neurobiol.
  doi: 10.1016/S0301-0082(99)00042-8
– volume: 70
  start-page: 2082
  year: 1998
  ident: 346417_CR25
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1998.70052082.x
– volume: 90
  start-page: 7951
  year: 1993
  ident: 346417_CR14
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.90.17.7951
– volume: 273
  start-page: 7228
  year: 1998
  ident: 346417_CR5
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.13.7228
– volume: 49
  start-page: 229
  year: 1997
  ident: 346417_CR12
  publication-title: J. Neurosci. Res.
  doi: 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W
– volume: 12
  start-page: 2735
  year: 2000
  ident: 346417_CR9
  publication-title: Eur. J. Neurosci.
  doi: 10.1046/j.1460-9568.2000.00164.x
– volume: 5
  start-page: 69
  year: 1995
  ident: 346417_CR16
  publication-title: Growth Reg.
– volume: 24
  start-page: 78
  year: 1998
  ident: 346417_CR7
  publication-title: J. Pineal Res.
  doi: 10.1111/j.1600-079X.1998.tb00370.x
– volume: 9
  start-page: 180
  year: 1997
  ident: 346417_CR23
  publication-title: Curr. Opinion Cell Biol.
  doi: 10.1016/S0955-0674(97)80061-0
– volume: 72
  start-page: 2248
  year: 1999
  ident: 346417_CR27
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.0722248.x
– volume: 69
  start-page: 273
  year: 1997
  ident: 346417_CR11
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1997.69010273.x
– volume: 288
  start-page: 163
  year: 2000
  ident: 346417_CR26
  publication-title: Neurosci. Lett.
  doi: 10.1016/S0304-3940(00)01229-5
– volume: 65
  start-page: 1487
  year: 1995
  ident: 346417_CR1
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1995.65041487.x
– volume: 38
  start-page: 7609
  year: 1999
  ident: 346417_CR10
  publication-title: Biochemistry
  doi: 10.1021/bi990438f
– volume: 46
  start-page: 187
  year: 1995
  ident: 346417_CR17
  publication-title: Meth. Cell Biol.
  doi: 10.1016/S0091-679X(08)61930-5
– volume: 9
  start-page: 726
  year: 1995
  ident: 346417_CR28
  publication-title: FASEB J.
  doi: 10.1096/fasebj.9.9.7601337
– volume: 77
  start-page: 817
  year: 1994
  ident: 346417_CR2
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90131-7
– volume: 274
  start-page: 23570
  year: 1999
  ident: 346417_CR6
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.33.23570
– volume: 76
  start-page: 389
  year: 2000
  ident: 346417_CR8
  publication-title: Mol. Brain Res.
  doi: 10.1016/S0169-328X(00)00025-5
– volume: 31
  start-page: 1269
  year: 1999
  ident: 346417_CR20
  publication-title: J. Mol. Cell Cardiol.
  doi: 10.1006/jmcc.1999.0959
– volume: 152
  start-page: 871
  year: 1998
  ident: 346417_CR21
  publication-title: Dis. Am. J. Pathol.
– volume: 3
  start-page: 38
  year: 2000
  ident: 346417_CR24
  publication-title: Neurosci. News
– volume: 71
  start-page: 621
  issue: Suppl.
  year: 2000
  ident: 346417_CR4
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/71.2.621s
– volume: 8
  start-page: 220
  year: 1998
  ident: 346417_CR19
  publication-title: Trends Cardiovasc. Med.
  doi: 10.1016/S1050-1738(98)00012-7
– volume: 83
  start-page: 345
  year: 1998
  ident: 346417_CR29
  publication-title: Circ. Res.
  doi: 10.1161/01.RES.83.4.345
– volume: 754
  start-page: 65
  year: 1997
  ident: 346417_CR22
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(97)00043-7
– volume: 891
  start-page: 185
  year: 2001
  ident: 346417_CR30
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(00)02965-6
– volume: 71
  start-page: 248
  year: 1976
  ident: 346417_CR3
  publication-title: Ann. Biochem.
  doi: 10.1016/0003-2697(76)90527-3
– reference: 9721691 - Circ Res. 1998 Aug 24;83(4):345-52
– reference: 10759064 - Prog Neurobiol. 2000 May;61(1):45-60
– reference: 14987568 - Trends Cardiovasc Med. 1998 Jul;8(5):220-8
– reference: 7601337 - FASEB J. 1995 Jun;9(9):726-35
– reference: 10386999 - Biochemistry. 1999 Jun 15;38(24):7609-16
– reference: 10371701 - J Mol Cell Cardiol. 1999 Jun;31(6):1269-79
– reference: 11164822 - Brain Res. 2001 Feb 9;891(1-2):185-96
– reference: 9272645 - J Neurosci Res. 1997 Jul 15;49(2):229-35
– reference: 942051 - Anal Biochem. 1976 May 7;72:248-54
– reference: 10681270 - Am J Clin Nutr. 2000 Feb;71(2):621S-629S
– reference: 7643105 - J Neurochem. 1995 Sep;65(3):1282-9
– reference: 7541884 - Methods Cell Biol. 1995;46:187-216
– reference: 10762716 - Brain Res Mol Brain Res. 2000 Mar 29;76(2):389-95
– reference: 9546346 - Am J Pathol. 1998 Apr;152(4):871-7
– reference: 9516415 - J Biol Chem. 1998 Mar 27;273(13):7228-34
– reference: 10438538 - J Biol Chem. 1999 Aug 13;274(33):23570-6
– reference: 9069255 - Curr Opin Cell Biol. 1997 Apr;9(2):180-6
– reference: 8004671 - Cell. 1994 Jun 17;77(6):817-27
– reference: 10971616 - Eur J Neurosci. 2000 Aug;12(8):2735-45
– reference: 10876086 - Neurosci Lett. 2000 Jul 14;288(2):163-6
– reference: 9202320 - J Neurochem. 1997 Jul;69(1):273-84
– reference: 7627094 - Growth Regul. 1995 Jun;5(2):69-84
– reference: 9572294 - J Neurochem. 1998 May;70(5):2082-90
– reference: 10349832 - J Neurochem. 1999 Jun;72(6):2248-55
– reference: 10461910 - J Neurochem. 1999 Sep;73(3):1181-8
– reference: 7561842 - J Neurochem. 1995 Oct;65(4):1487-98
– reference: 9134960 - Brain Res. 1997 Apr 18;754(1-2):65-71
– reference: 8367446 - Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5
– reference: 9510431 - J Pineal Res. 1998 Mar;24(2):78-82
SSID ssj0003519
Score 1.7915341
Snippet The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 175
SubjectTerms Alzheimer Disease - etiology
Alzheimer Disease - metabolism
Amyloid beta-Peptides - metabolism
Amyloid beta-Peptides - toxicity
Biological and medical sciences
Blotting, Western
Coloring Agents
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dose-Response Relationship, Drug
extracellular signal-regulated kinase
Hydrogen Peroxide - metabolism
In Vitro Techniques
MAP Kinase Signaling System - drug effects
Medical sciences
Mitogen-Activated Protein Kinases - metabolism
Neuroblastoma - enzymology
Neuroblastoma - metabolism
Neurology
p38 Mitogen-Activated Protein Kinases
Phosphorylation
Tetrazolium Salts
Thiazoles
Tropical medicine
Tumor Cells, Cultured
Title The Role of the MAP-Kinase Superfamily in β-Amyloid Toxicity
URI https://www.ncbi.nlm.nih.gov/pubmed/11769330
https://www.proquest.com/docview/18352371
https://www.proquest.com/docview/72369611
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitswEBXtLpRCKb03vaR-aKEQHCz5_uhNXDbpJizZBPJmZFmipq0TNjYt_ax-SL-pI8uXOG3o5UUEo1iJ5mh0RjOaQeg1SwybCcZ1ZglThx3K0Knnxjp2jUSQODE9VgbIzp3zlTVd2-v2VKm8XZLHQ_btt_dK_keq8AzkKm_J_oNkm5fCA_gM8oUWJAztX8u4Dg-UBHIWXOof0ww2psGu2PLr6vQiBQGPwjdnRKefwT5PEyCcX1OW5h2X7oznAAiZ8zqWZSMOXTfjYD4JVaBfeUYDow0HqwYV4Xy8mIzeX6nIW7aJi4asXwUXkzLmclEkxRfawnEZXEyDYDGuPBEfCjqYDqtQ4_ogAh8EddQHkR0FZuuupcqBNtrW2UNVfcNHKU-saqhU-zBWpXx-UfH7qSaAnVnQAmc02_2s9uEfbHNN8CE2gSJatn0TnRIXCBcoQXfdWOnSs-or00P9-IN8UHtDdqjMnS3dwaoSqhzKcXul5C3Le-huZXBogULPfXSDZw_QrVkVUvEQSRBpEkTaRmgAIq0FkbYHIi3NtB_fawBpNYAeodW7cDk616uaGjqDP53r3CXMIa5nM4t63I9NQziUYGFZMcaxzzAsTg6LFxMgT05iUd8QXuJwh9qOSYGvP0Yn2SbjT5HGY-bL9G6-ByTW5sLnxHAIE1aCHZv5vIeG9fRErEo4L-uefIrKwAdiRkHUmc8eett8YatyrRzv2u_Md9u_Em4PvaoFEIHClF4wmvFNsYuwtDlMFx_v4RJZ5BJDjydKcu3bsSwdahrP_jT8c3S7XSIv0El-XfCXwF7zuF-irY9Oz8L55eInfhmUnQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+the+MAP-kinase+superfamily+in+%CE%B2-amyloid+toxicity&rft.jtitle=Metabolic+brain+disease&rft.au=DANIELS%2C+Willie+M.+U&rft.au=HENDRICKS%2C+Jacobus&rft.au=SALIE%2C+Ruduwaan&rft.au=TALJAARD%2C+Joshua+J.+F&rft.date=2001-12-01&rft.pub=Springer&rft.issn=0885-7490&rft.volume=16&rft.issue=3-4&rft.spage=175&rft.epage=185&rft_id=info:doi/10.1023%2FA%3A1012541011123&rft.externalDBID=n%2Fa&rft.externalDocID=13435455
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-7490&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-7490&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-7490&client=summon